跳至主要内容
临床试验/NCT05377606
NCT05377606已完成不适用

Macular Perfusion and Sensitivity Following Silicone Oil Tamponade Versus SF6 Gas for Primary Rhegmatogenous Retinal Detachment

Cairo University2 个研究点 分布在 1 个国家目标入组 62 人开始时间: 2021年12月23日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
62
试验地点
2
主要终点
Macular perfusion - SVP

研究概览

简要总结

Rhegmatogenous retinal detachment (RRD) is the separation of the neurosensory retina from the retinal pigment epithelium caused by the presence of a break that leads to the passage of fluid from the vitreous cavity into the potential subretinal space. It is a sight threatening disease, affecting largely people 50 years or older, with an annual incidence varying between 6.3 and 17.9 people per 100,000 population, and is unfortunately increasing. Although other surgical options do exist for the repair of primary RRD, pars plana vitrectomy (PPV) has clear advantages and is certainly effective in the treatment of these patients.

Several agents are used for intraocular tamponade following PPV for RRD. These agents are either silicone oil (SO) or gases like air, perfluoropropane (C3F8), sulfur hexafluoride (SF6), or perfluoroethane (C2F6).

In addition to the complications uniquely peculiar to using SO, research has found out that a reduction in retinal sensitivity on microperimetry was greater in SO tamponade in comparison with gas, as well as poorer visual outcome, microvasculature damage and affection of retinal layers including ganglion cell complex (GCC) in the SO group.

Even though many studies were done to compare between SO and intraocular gas tamponades with respect to many aspects, only one study compared the effects SO had on macular vasculature and anatomy in comparison with air and no study at all to date has compared the SO to SF6 gas in terms of retinal vascular changes, correlating them to thinning of GCC and macular sensitivity, which is precisely the main aim of the current study.

详细描述

Rhegmatogenous retinal detachment (RRD) is the separation of the neurosensory retina from the retinal pigment epithelium (RPE) caused by the presence of a break that leads to the passage of fluid from the vitreous cavity into the potential subretinal space. It is a sight threatening disease, affecting largely people 50 years or older, with an annual incidence varying between 6.3 and 17.9 people per 100,000 population, and is unfortunately increasing. Although other surgical options do exist for the repair of primary RRD, viz. scleral buckling and pneumatic retinopexy, primary pars plana vitrectomy (PPV) has clear advantages and is certainly effective in the treatment of these patients, with a primary success rate of 85%, making it the leading management modality.

Several agents are used for intraocular tamponade following PPV for RRD, in order to provide surface tension across the retinal breaks thus preventing the ingress once more of fluid into the subretinal space, giving time for the permanent seal provided by the retinopexy done whether photocoagulation or cryopexy. These agents are either silicone oil (SO) or gases like air, perfluoropropane (C3F8), sulfur hexafluoride (SF6), or perfluoroethane (C2F6).

In addition to the complications uniquely peculiar to using SO, research has found out that a reduction in retinal sensitivity on microperimetry was greater in SO tamponade in comparison with gas, as well as poorer visual outcome, microvasculature damage and affection of retinal layers including ganglion cell complex (GCC) in the former group leading to the so-called Silicone Oil-Related Visual Loss (SORVL).

Even though many studies were done to compare between SO and intraocular gas tamponades with respect to many aspects, only one study by Zhou et al in 2020 compared the effects SO endotamponade had on macular vasculature and anatomy in comparison with sterilized air tamponade and no study at all to date has compared the SO to SF6 gas in terms of retinal vascular changes, correlating them to thinning of GCC and macular sensitivity, which is precisely the main aim of the current study.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Care Provider)

盲法说明

Surgeon will be masked to the tamponading agent (silicone oil or gas) till the end of the operation when either agent will be injected.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Primary rhegmatogenous retinal detachment

排除标准

  • Macula-on retinal detachment
  • Change of decision of type of endotamponade used intraoperatively
  • Giant retinal tear
  • Proliferative vitreoretinopathy worse than grade B
  • Recent lens surgery within the previous 3 months prior to presentation
  • Prior vitreoretinal surgery
  • Macular hole
  • Signs of epiretinal membrane
  • Diabetic retinopathy
  • Macular degeneration or other macular disorders
  • Inferior retinal breaks between 4 and 8 o'clock
  • History of uveitis
  • History of glaucoma

结局指标

主要结局

Macular perfusion - SVP

时间窗: At 2 and 4 months following primary vitrectomy

Comparison of superficial retinal capillary vascular density between the different treatment arms.

Macular perfusion - FAZ

时间窗: At 2 and 4 months following primary vitrectomy

Comparison of foveal avascular zone area between the different treatment arms as a measure of macular perfusion.

Macular perfusion - DVP

时间窗: At 2 and 4 months following primary vitrectomy

Comparison of deep retinal capillary vascular density between the different treatment arms.

次要结局

  • Best corrected visual acuity(At 2 and 4 months following primary vitrectomy)
  • Retinal reattachment rate(At 4 months following primary vitrectomy)
  • Macular sensitivity(At 2 and 4 months following primary vitrectomy)
  • Thickness of ganglion cell complex(At 2 and 4 months following primary vitrectomy)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mina Safe Abdelmesih Abdelmalak

Assistant Lecturer

Cairo University

研究点 (2)

Loading locations...

相似试验